Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Stephane Quideau
Introduction
Stephane Quideau is a notable inventor based in Talence, France. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of antiviral treatments. His work focuses on combating viral infections, specifically those caused by influenza viruses.
Latest Patents
Quideau holds a patent for "Antiviral compositions directed against the influenza virus nucleoprotein." This pharmaceutical composition is designed to treat viral infections caused by influenza type A viruses. It includes a compound that acts as an inhibitor of the binding of viral RNA to the nucleoprotein of these viruses. Additionally, the patent describes a method for identifying compounds with these properties, which could lead to more effective treatments for viral infections.
Career Highlights
Stephane Quideau is affiliated with the Institut National de la Recherche Agronomique, where he conducts his research and development. His work has been instrumental in advancing the understanding of antiviral mechanisms and developing new therapeutic strategies.
Collaborations
Quideau has collaborated with esteemed colleagues such as Anny Slama Schwok and Bernard Delmas. These partnerships have enriched his research and contributed to the success of his innovative projects.
Conclusion
Stephane Quideau's contributions to antiviral research highlight the importance of innovation in the pharmaceutical industry. His work not only addresses pressing health challenges but also paves the way for future advancements in treating viral infections.